Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

1. Instructions Component RO MODEL TECHNICAL COMPONENT WORK BOOK INSTRUCTIONS This work book is designed to assist RO Model participants as they determine the impact of the RO Model on practice revenues. In order to complete this work book, each RO Model participant must follow these steps: Once RO Model participants have identified the data points below, they should complete …
1. Instructions Component RO MODEL PROFESSIONAL COMPONENT WORK BOOK INSTRUCTIONS This work book is designed to assist RO Model participants as they determine the impact of the RO Model on practice revenues. In order to complete this work book, each RO Model participant must follow these steps: Once RO Model participants have identified the data points below, they should complete …
PowerPoint Presentation BACKGROUND Leigh Boehmer, PharmD, BCOP Medical Director Association of Community Cancer Centers 1801 Research Blvd, Ste 400, Rockville, MD 20850 lboehmer@accc-cancer.org For more information about the ACCC Immuno-Oncology Institute, please visit accc-cancer.org/immunotherapy ACKNOWLEDGEMENTS An Immuno-Oncology Census: Assessment of Clinician Knowledge …
Presented at the SITC Annual Conference.
MRSA/MSSA Respiratory NAAT Secondary Myeloid Malignancies after Autologous Stem Cell Transplantation for Multiple Myeloma Are Associated with a Distinct Mutational Profile Ariel Kleman, Arun K Singavi, Lauren Pommert, Michael Zimmerman, Wendy Demos, Angela Mathison, Sridhar Rao, Karen Carlson, Parameswaran Hari. Medical College of Wisconsin | Milwaukee, WI Background Objectives …
Slide 1 Population Level Outcomes of Chronic Lymphocytic Leukemia in the Era of Targeted Agents- Analysis of Surveillance Epidemiology and End Results (SEER) Database Ravi Kishore Narra MD1, Ehab Atallah MD1, Mehdi Hamadani MD1 , Guru Subramanian Guru Murthy MD MS1 1 Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI BACKGROUND METHODS RESULTS …
CCMED_9_12_Infographic_Sep_18_2020 Staging and Testing for Stage III/IV Non-Small Cell Lung Cancer: Perspectives from Pathologists and Pulmonologists in US cancer care programs Improving pathologist and pulmonologist know-how on diagnostic modalities and alleviating barriers to care delivery can optimize care for stage III/IV NSCLC patients Accurate staging and testing using …
November 10, 2020
Lacy Sheets, MBA, Manager Revenue Cycle, St. Luke's Health System Rifeta Kajdic, Oncology Program Manager, St. Luke's Health System Gina Hampton, Revenue Application Specialist, St. Luke's Health System Effectively tracking patient applications for free medications or copay assistance can be an unwieldy, time-consuming, and frustrating task, putting patients at risk of falling through the cracks. By …
Ravi Kishore Narra, MD, et al., UW Health, Madison, WI View Poster
Ariel Kleman et al., University of Wisconsin Madison, WI View Poster
The Association of Cancer Care Centers (ACCC) has a long and successful history working with our national corporate partners to support them in better understanding the landscape of community oncology in today’s ever-changing healthcare environment. More specifically, ACCC helps our partners to better navigate the extraordinary challenges happening in oncology programs and practices through the lens …
Learn about the role of the interdisciplinary cancer team in managing oral chemotherapy for patients with cancer, and discover how one cancer program has improved their workflow while keeping the patient at the center.
Sam Z. Thalji et al., UW Health, Madison, WI View Poster
N. Sich et al., UW Health, Madison, WI View Poster
A. Retzlaff et al., UW Health, Madison, WI View Poster
Jeremy D. Kratz et al., UW Health, Madison, WI View Poster
Background Background Experience with 177Lu-Dotatate Therapy for Metastatic Neuroendocrine Cancer at a Quarternary Comprehensive Cancer Center Sich N, Kriley I, Chevinsky A, Sanchez F. Objective Determine the effectiveness of 177Lu-Dotatate therapy in a community cancer program through evaluation of clinical symptomatic response as well as RECIST criteria on serial imaging. …
PowerPoint Presentation Transition from chemotherapy (systemic) to radiotherapy (local) • CA19-9 trend may have utility in identifying distant disease in the absence of any radiologic or other indication of metastasis CA19-9 is the most important biomarker for PC1 • Normalization of CA19-9 during neoadjuvant treatment is associated with dramatically improved survival2 • Less …
PowerPoint Presentation A Phase I Trial of Neoadjuvant SBRT with Elective Nodal Radiation for Resectable Pancreas Cancer BACKGROUND RESULTS Pancreatic cancer (PDA) is a highly lethal malignancy with a high rate of local and regional relapse, even among patients with resectable disease. Prior data from randomized trials have indicated improved local control when adding radiation in the …
PowerPoint Presentation